In enzymology, a cholest-5-ene-3ò,7ñ-diol 3ò-dehydrogenase () is an enzyme that catalyzes several chemical reactions of steroids.
The primary reaction is to convert 7ñ-hydroxycholesterol to 7ñ-hydroxycholest-4-en-3-one:
The two substrates are 7ñ-hydroxycholesterol and oxidised nicotinamide adenine dinucleotide (NAD<sup>+</sup>). The products are 7ñ-hydroxycholest-4-en-3-one, reduced NADH, and a proton.
The systematic name of this enzyme class is cholest-5-ene-3ò,7ñ-diol:NAD<sup>+</sup> 3-oxidoreductase. This enzyme is also called 3ò-hydroxy-ÃÂ5-C27-steroid oxidoreductase. The human version of this enzyme is known as hydroxy-ÃÂ-5-steroid dehydrogenase, 3 ò- and steroid delta-isomerase 7 or HSD3B7 which is encoded by the HSD3B7 gene.
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD<sup>+</sup> or NADP<sup>+</sup> as acceptor. This enzyme is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily. This enzyme is a membrane-associated endoplasmic reticulum protein which is active against 7-alpha hydroxylated sterol substrates.
Mutations in the HSD3B7 gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, a form of progressive liver disease.